Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 25 2025
0mins
Source: Globenewswire
Event Announcement: Eledon Pharmaceuticals will host an R&D Day in New York City on July 9, 2025, featuring discussions on their investigational candidate tegoprubart and advancements in organ transplantation.
Company Overview: Eledon is a clinical-stage biotechnology company focused on immune-modulating therapies, particularly targeting CD40L for conditions like kidney transplantation and ALS, with ongoing clinical studies and strategic opportunities in transplantation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
